The Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) is a consortium composed of the Partnership for Dengue Control (PDC), the International Vaccine Institute (IVI), the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health and the Sabin Vaccine Institute. The World Health Organization advises and collaborates with GDAC.
Promising New Tools
Promising new tools such as vaccines, therapeutics and vector control methods are expected to become available in the next three to five years, but none will likely halt the spread of Aedes-transmitted diseases if used alone. Countries will need to determine the most cost-effective way to implement these tools in an integrated manner. High quality disease and vector surveillance data, reliable diagnostics, trained staff and coordinated application will be required at a local, national and international level.